Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
Article has an altmetric score of 3

See more details

Referenced in 1 patents
7 readers on Mendeley
  • Article usage
  • Citations to this article (154)

Advertisement

Research Article Free access | 10.1172/JCI105947

Studies on collagenase from rheumatoid synovium in tissue culture

John M. Evanson, John J. Jeffrey, and Stephen M. Krane

Department of Medicine, Harvard Medical School, Boston, Massachusetts 02114

Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114

Find articles by Evanson, J. in: PubMed | Google Scholar

Department of Medicine, Harvard Medical School, Boston, Massachusetts 02114

Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114

Find articles by Jeffrey, J. in: PubMed | Google Scholar

Department of Medicine, Harvard Medical School, Boston, Massachusetts 02114

Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114

Find articles by Krane, S. in: PubMed | Google Scholar

Published December 1, 1968 - More info

Published in Volume 47, Issue 12 on December 1, 1968
J Clin Invest. 1968;47(12):2639–2651. https://doi.org/10.1172/JCI105947.
© 1968 The American Society for Clinical Investigation
Published December 1, 1968 - Version history
View PDF
Abstract

Fragments of synovium from patients with rheumatoid arthritis survive in defined tissue culture medium in the absence of added serum and, after 3-4 days, release into the medium enzyme capable of degrading undenatured collagen. Maximal activity is observed at pH 7-9 but the enzyme is inactive at pH 5. At temperatures of 20° and 27°C, collagen molecules in solution are cleaved into 3/4 and 1/4 length fragments with minimal loss of negative optical rotation, but with loss in specific viscosity of approximately 60%. Above 30°C the fragments begin to denature and denaturation is complete at 37°C. If the enzyme is not inhibited at this stage the large fragments are broken down further to polypeptides of low molecular weight. Reconstituted collagen fibrils and native fibers at 37°C are cleaved to the low molecular weight fragments, although the fibrils are resistant to breakdown at lower temperatures (20°-27°C). It is proposed that the production of such an enzyme by inflamed and proliferating rheumatoid synovium may be responsible for some of the destruction of collagenous structures that accompanies rheumatoid arthritis.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 2639
page 2639
icon of scanned page 2640
page 2640
icon of scanned page 2641
page 2641
icon of scanned page 2642
page 2642
icon of scanned page 2643
page 2643
icon of scanned page 2644
page 2644
icon of scanned page 2645
page 2645
icon of scanned page 2646
page 2646
icon of scanned page 2647
page 2647
icon of scanned page 2648
page 2648
icon of scanned page 2649
page 2649
icon of scanned page 2650
page 2650
icon of scanned page 2651
page 2651
Version history
  • Version 1 (December 1, 1968): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

Article has an altmetric score of 3
  • Article usage
  • Citations to this article (154)

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 patents
7 readers on Mendeley
See more details